Joseph T Rabban

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours
    Joseph T Rabban
    Pathology Department, University of California San Francisco, San Francisco, CA, USA
    Histopathology 62:71-88. 2013
  2. doi request reprint Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations
    Joseph T Rabban
    Department of Pathology, Cancer Risk Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA
    Am J Surg Pathol 33:111-9. 2009
  3. doi request reprint Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, San Francisco, California 94143, USA
    Int J Gynecol Pathol 28:41-8. 2009
  4. doi request reprint Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma
    Joseph T Rabban
    Department of Pathology, University of California, M 551 San Francisco, California 94143, USA
    Am J Surg Pathol 33:1125-36. 2009
  5. doi request reprint Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol
    Joseph T Rabban
    Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA
    Am J Surg Pathol 33:1878-85. 2009
  6. doi request reprint D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Hum Pathol 39:175-83. 2008
  7. doi request reprint PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, M 551, San Francisco, CA 94143, USA
    Am J Surg Pathol 34:137-46. 2010
  8. doi request reprint Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94313, USA
    Gynecol Oncol 121:466-71. 2011
  9. ncbi request reprint Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor
    Joseph T Rabban
    Department of Pathology, University of California, San Francisco, CA 94143, USA
    Gynecol Oncol 103:1164-8. 2006
  10. ncbi request reprint HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma
    Joseph T Rabban
    Department of Pathology, University of California, San Francisco, 94193, USA
    Int J Gynecol Pathol 25:403-7. 2006

Collaborators

Detail Information

Publications29

  1. doi request reprint A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours
    Joseph T Rabban
    Pathology Department, University of California San Francisco, San Francisco, CA, USA
    Histopathology 62:71-88. 2013
    ..In addition, the limited role of immunohistochemistry in determining the primary site of origin of an ovarian carcinoid tumour is discussed...
  2. doi request reprint Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations
    Joseph T Rabban
    Department of Pathology, Cancer Risk Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA
    Am J Surg Pathol 33:111-9. 2009
    ..This study demonstrates that transitional cell metaplasia of the fimbriae is a common benign finding in RRSO specimens that should not be confused with the much less common finding of tubal intraepithelial carcinoma...
  3. doi request reprint Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, San Francisco, California 94143, USA
    Int J Gynecol Pathol 28:41-8. 2009
    ....
  4. doi request reprint Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma
    Joseph T Rabban
    Department of Pathology, University of California, M 551 San Francisco, California 94143, USA
    Am J Surg Pathol 33:1125-36. 2009
    ....
  5. doi request reprint Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol
    Joseph T Rabban
    Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA
    Am J Surg Pathol 33:1878-85. 2009
    ..Guidelines for evaluation of RRSO specimens should emphasize the use of an optimal dissection protocol and the importance of thin tissue slice intervals...
  6. doi request reprint D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Hum Pathol 39:175-83. 2008
    ..We recommend that myoepithelial markers be used in conjunction with D2-40 to distinguish solid intralymphatic tumor emboli from solid pattern in situ carcinoma...
  7. doi request reprint PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, M 551, San Francisco, CA 94143, USA
    Am J Surg Pathol 34:137-46. 2010
    ..001); however, PAX2 should not be interpreted in isolation from the architectural and cytologic features of the lesion as it may be expressed in some stage II endometrial adenocarcinomas involving the cervix...
  8. doi request reprint Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94313, USA
    Gynecol Oncol 121:466-71. 2011
    ..The aim of this study was to correlate the macroscopic and microscopic pathologic findings in RRSO...
  9. ncbi request reprint Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor
    Joseph T Rabban
    Department of Pathology, University of California, San Francisco, CA 94143, USA
    Gynecol Oncol 103:1164-8. 2006
    ..The endometrial carcinoma is thought to occur under the influence of the estrogen receptor pathway and is typically a low-grade, low-stage endometrioid adenocarcinoma...
  10. ncbi request reprint HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma
    Joseph T Rabban
    Department of Pathology, University of California, San Francisco, 94193, USA
    Int J Gynecol Pathol 25:403-7. 2006
    ..HMGA2 involvement has also been described in a variety of benign gynecologic mesenchymal neoplasms. We report an additional case of HMGA2 rearrangement in vulvar aggressive angiomyxoma, using fluorescence in situ hybridization...
  11. ncbi request reprint Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers
    Joseph T Rabban
    Department of Pathology, University of California, San Francisco, CA 94143, USA
    Mod Pathol 19:1351-7. 2006
    ..Reliance on p63 or smooth muscle actin alone poses a potential diagnostic pitfall in evaluating cribriform breast lesions...
  12. ncbi request reprint Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Hum Pathol 37:787-93. 2006
    ..Pathologists must guard against misinterpreting SP-DCIS as UDH in those cases in which the carcinoma cells engulf cytokeratin 5/6-expressing residual, native epithelial cells...
  13. doi request reprint Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Am J Surg Pathol 33:256-63. 2009
    ..D2-40 immunostaining is useful in this setting. Current staging criteria should be clarified to define whether extensive intralymphatic tumor should be incorporated in tumor stage assignment...
  14. doi request reprint Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol
    C Bethan Powell
    Cancer Risk Program, Department of Pathology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA
    Int J Gynecol Cancer 21:846-51. 2011
    ..We report outcomes in 111 consecutive BRCA-positive women who had RRSO using a rigorous surgical-pathological protocol from 1996 to 2008...
  15. doi request reprint COMT polymorphisms affecting protein expression are risk factors for endometrial cancer
    Hiroshi Hirata
    Department of Urology, Veterans Affairs Medical Center and University of California at San Francisco, San Francisco, California 94121, USA
    Mol Carcinog 47:768-74. 2008
    ..This is the first study demonstrating that polymorphisms in COMT codon 62 and codon 158 altered protein expression levels in EC, suggesting that they may be risk factors for EC in Caucasians...
  16. pmc Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics
    Nancy Dumont
    Department of Pathology and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA
    Neoplasia 15:249-62. 2013
    ..Our results suggest that normalizing the organization of the ECM could be effective in limiting systemic dissemination and tumor growth...
  17. doi request reprint Decidualized endometrioma during pregnancy: recognizing an imaging mimic of ovarian malignancy
    Liina Poder
    Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    J Comput Assist Tomogr 32:555-8. 2008
    ....
  18. doi request reprint Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma
    Anthony N Karnezis
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143 0102, USA
    Am J Surg Pathol 37:24-37. 2013
    ....
  19. doi request reprint Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis
    Elizabeth M Hosfield
    Department of Pathology, University of California, San Francisco, California 94143, USA
    Int J Gynecol Pathol 27:465-74. 2008
    ..Dialysis-associated changes involving the ovary and fallopian tube form a mechanical barrier that could contribute to the low rate of fertility in peritoneal dialysis patients...
  20. ncbi request reprint Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis
    Joseph T Rabban
    University of California San Francisco, Department of Anatomic Pathology, San Francisco, CA 94143, USA
    Pathology 39:125-33. 2007
    ..We review the diagnostic criteria for minimal USC, pitfalls in the differential diagnosis, and discuss a practical approach to evaluating biopsies, polypectomies, or hysterectomies containing minimal USC...
  21. ncbi request reprint Superficial endometrial spread of squamous cell cervical carcinoma: a diagnostic challenge at magnetic resonance imaging
    Felix Adler
    Department of Radiology, University of California, San Francisco, CA 94143 0628, USA
    J Comput Assist Tomogr 31:247-50. 2007
    ....
  22. doi request reprint Utility of the broccoli sign in the distinction of prolapsed uterine tumor from cervical tumor
    Priyanka Jha
    Department of Radiology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 0628, United States
    Eur J Radiol 81:1931-6. 2012
    ..To describe the utility, histopathological basis, and clinical correlates of the broccoli sign...
  23. doi request reprint Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability
    Anıl Aysal
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Am J Surg Pathol 36:163-72. 2012
    ..Thus, in patients with ovarian endometrioid adenocarcinoma who undergo uterus-sparing surgery, abnormal MMR/MSI should prompt further diagnostic evaluation of the endometrium for tumor...
  24. doi request reprint CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility
    Hiroshi Hirata
    Department of Urology, University of California at San Francisco, San Francisco, CA 94121, USA
    Cancer 112:1964-73. 2008
    ..The authors hypothesized that single nucleotide polymorphisms (single nucleotide polymorphisms) of CYP1A1, CYP1A2, CYP1B1, CYP17, SULT1A1, SULT1E1, and SHBG genes may be risk factors for endometrial cancer...
  25. pmc CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues
    Rosa Anna DeFilippis
    Department of Pathology, Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA
    Cancer Discov 2:826-39. 2012
    ..Levels of CD36 and extent of mammographic density are both modifiable factors that provide potential for intervention...
  26. ncbi request reprint Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors
    Joseph T Rabban
    Department of Anatomic Pathology, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    Am J Surg Pathol 29:1348-55. 2005
    ..ALK expression appears to be of diagnostic value in conjunction with other immunohistochemical stains...
  27. doi request reprint The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features
    Oluwole Fadare
    Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA
    Am J Surg Pathol 36:1107-18. 2012
    ..Cases that display broad and significant qualitative deviations from the aforementioned profile should prompt the consideration of a diagnosis other than CCC...
  28. ncbi request reprint Current issues in the pathology of ovarian cancer
    Joseph T Rabban
    Gillette Center in Women s Cancer Pathology and Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Reprod Med 50:467-74. 2005
    ..Special processing of the pathologic specimens is required to detect early and minimal neoplasia in this setting. These current issues in the pathology of ovarian carcinoma and their clinical significance form the basis of this review...
  29. ncbi request reprint Sclerosing lesions of the breast
    Joseph T Rabban
    James Homer Wright Pathology Laboratories, Molecular Pathology Unit, Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129, USA
    Semin Diagn Pathol 21:42-7. 2004
    ..Important diagnostic features of these lesions are highlighted and contrasted with those of invasive carcinoma...